ARTICLE | Finance

Alphamab's cancer cash

Alphamab Oncology to push several programs through the clinic with $100M A round

November 21, 2018 7:41 PM UTC

Alphamab Oncology spun out from Suzhou Alphamab Co. Ltd. and raised more than $100 million in a series A round to advance multiple cancer biologics through clinical testing.

Investors in the round, which closed on Nov. 17, include Advantech Capital, PAG, China Venture Capital Fund, OrbiMed Advisors, Heritage Provider Network and Janchor Partners...